Abstract
The myocardial Na+/H+ exchanger isoform 1 (NHE-1) represents a major H+ extrusion mechanism for intracellular pH (pHi) regulation especially during ischaemia and early reperfusion. Paradoxically, however, its activation contributes to induction of cell injury because Na+/H+ exchange is coupled closely to elevations in intracellular [Ca2+] through the Na+/Ca2+ exchanger. NHE-1 is exquisitely sensitive to intracellular acidosis but other factors may have also stimulatory effects via phosphorylation-dependent processes, like autocrine and paracrine agents as well as hormonal factors such as endothelin-1, angiotensin II and α-1-adrenoceptor agonists. In addition, phosphorylation-independent NHE-1 activation mechanisms are known, e.g. cell shrinkage.
To date at least 8 NHE isoforms have been identified and designated as NHE-1–8. All, except NHE-6 and NHE-7, which are located intracellularly, are restricted to the sarcolemmal membrane. The NHE-1 subtype is the predominant isoform in the heart, but NHE-6 is also expressed in the heart. Newly developed, selective NHE-1 inhibitors possess potent cardioprotective properties. The efficacy of NHE-1 inhibitors in experimental studies with ischaemia/reperfusion has led to clinical trials for the evaluation of these agents in high-risk patients with coronary artery disease (GUARDIAN Trial) and acute myocardial infarction (ESCAMI Trial). The GUARDIAN trial demonstrated only for the coronary artery by-pass graft (CABG) patient population a reduction in the primary cardiovascular endpoint (death and reoccurring myocardial infarction). However, recent evidence also suggests that NHE-1 inhibition may be conducive to attenuation of remodelling processes after myocardial infarction, independently of infarct size reduction and blood pressure. In addition, in separate preclinical studies, the NHE-1 inhibitor cariporide also prevented and/or caused regression of age-related and hypertension-induced myocardial fibrosis and hypertrophy.
NHE-1 inhibitors thus offer substantial promise for clinical development for attenuation of both a) acute responses to myocardial injury, b) chronic post-infarct and hypertension- and age-related responses resulting in the development of heart failure.
Similar content being viewed by others
References
Aharonovitz O, Zaun HC, Balla T, York JD, Orlowski J, Grinstein S (2000) Intracellular pH regulation by Na+/H+ exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol 150:213–224
Altemose GT, Zipes DZ, Weksler J, Miller JM, Olgin JE (2001) Inhibition of the Na+/H+ exchanger delays the development of rapid pacing-induced atrial contractile dysfunction. Circulation 103:762–768
Avkiran M (2001) Protection of the ischemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic Res Cardiol 96:306–311
Avkiran M, Marber MS (2002) Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Col Cardiol 39:747–753
Avkiran M, Snabaitis AK (2001) Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress. J Thromb Thrombolysis 8:25–31
Avkiran M, Yokoyama H (2000) Adenosine A1 receptor stimulation inhibits alpha1-adrenergic activation of the cardiac sarcolemmal Na+/H+ exchanger. Br J Pharmacol 131:659–662
Ayoub IM, Kolarova J, Yi Z, Trevedi A, Deshmukh H, Lubell DL, Franz MR, Maldonado FA, Gazmuri RJ (2003) Sodium-hydrogen exchange inhibition during ventricular fibrillation. Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 107:1804–1809
Baartscheer A, Schumacher CA, van Borren MMGJ, Belterman CNW, Coronel R, Fiolet JWT (2003) Increased Na+/H+-exchange activity is the cause of increased [Na+] and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57:1015–1024
Baird NR, Orlowski J, Szabό EZ, Zaun HC, Schultheis PJ, et al. (1999) Molecular cloning, genomic organization, and functional expression of Na+/H+ exchanger isoform 5 (NHE5) from human brain. J Biol Chem 274:4377–4382
Becker RHA, Linz W, Schölkens BA (1989) Pharmacological interference with the cardiac renin angiotensin system. J Cardiovasc Pharmacol 14 (suppl. 4):S10–S15
Bianchini L, L'Allemain G, Pouysségur J (1997) The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE-1 isoform) in response to growth factors. J Biol Chem 272:271–279
Biemesderfer D, Pizzonia J, Abu-Alfa A, Exner M, Reilly R, et al. (1993) NHE3: a Na+/H+ exchanger isoform of renal brush border. Am J Physiol 265:F736–F742
Bookstein C, Xie Y, Rabenau K, Musch MW, McSwine RL, et al. (1997) Tissue distribution of Na+/H+ exchanger isoforms NHE2 and NHE4 in rat intestine and kidney. Am J Physiol 273:C1496–C1505
Brett CL, Wie Y, Donowitz M, Rao R (2002) Human Na+/H+ exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. Am J Physiol 282:C1031–C1041
Burckhardt G, Di Sole F, Helmle-Kolb C (2002) The Na+/H+ exchanger gene family. J Nephrol 15 (suppl. 5):S3–S21
Camilion de Hurtado M, Portiansky E, Perez N, Rebolledo OR, Cingolani HE (2002) Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+/H+ exchanger. Cardiovasc Res 53:862–868
Chen L, Gan XT, Haist JV, Feng Q, Lu X, Chakrabarti S, Karmazyn M (2001) Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+/H+ exchange inhibitor cariporide. J Pharmacol Exp Ther 298:469–476
Cingolani HE (1999) Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc Res 44:462–467
Cingolani HE, Rebolledo OR, Portiansky EL, Perez NG, de Hurtado MCC (2003) Regression of hypertensive myocardial fibrosis by Na+/H+ exchange inhibition. Hypertension 41:373–377
Clerk A, Sugden PH (1999) Activation of protein kinase cascades in the heart by hypertrophic G protein coupled receptor agonists. Am J Cardiol 83:64H–69H
Counillon L, Pouysségur J (2000) The expanding family of eucaryotic Na+/H+ exchangers. J Biol Chem 275:1–4
Counillon L, Scholz W, Lang HJ, Pouysségur J (1993) Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 44:1041–1045
Dyck JR, Lopaschuk GD (1998) Glucose metabolism, H+ production and Na+/H+ exchanger mRNA levels in ischemic hearts from diabetic rats. Mol Cell Biochem 180:85–93
Dyck JRB, Maddaford T, Pierce GN, Fliegel L (1995) Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res 29:203–208
Engelhardt S, Hein L, Keller U, Klaembt K, Lohse MJ (2002) Inhibition of Na+/H+ exchange prevents hypertrophy, fibrosis, and heart failure in β1-adrenergic receptor transgenic mice. Circ Res 90:814–819
Erhardt LR (1999) GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol 83:23G–25G
Fliegel L (1999) Functional and cellular regulation of the myocardial Na+/H+ exchanger. J. Thromb Thrombol 8:9–14
Fröhlich O, Karmazyn M (1997) The Na+/H+ exchanger revisited: an update on Na+/H+ exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res 36:138–148
Fujisawa G, Okada K, Muto S, Fujita N, Itabashi N, Kusano E, Ishibashi S (2003) Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury. Hypertension 41:493–498
Gan XT, Chakrabarti S, Karmazyn M (1999) Modulation of Na+/H+ exchange isoform 1 mRNA expression in isolated rat hearts. Am J Physiol 277:H993–H998
Gazmuri RJ, Hoffner E, Kalcheim J, Ho H, Patel M, Ayoub IM, Epstein M, Kingston S, Han Y (2001) Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med 137:43–55
Gazmuri RJ, Ayoub IM, Kolarova JD, Karmazyn M (2002) Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Crit Care Med 30:S166–S171
Goyal S, Vanden-Heuvel G, Aronson PS (2003) Renal expression of novel Na+/H+ exchanger isoform NHE-8. Am J Physiol 284:F467–F473
Gumina RJ, Buerger E, Eickmeier C, Moore J, Daemmgen J, Gross GJ (1999) Inhibition of the Na+/H+ exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation 100:2519–2526
Gumina RJ, Daemmgen J, Gross GJ (2000) Inhibition of the Na+/H+ exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol 396:119–124
Gumina RJ, Terzic A, Gross GJ (2001) Do NHE inhibition and ischemic preconditioning convey cardioprotection through a common mechanism? Basic Res Cardiol 96:318–324
Haist JV, Hirst CN, Karmazyn M (2003) Effective protection by NHE1 inhibition in ischemic and reperfused heart under preconditioning blockade. Am J Physiol 284:H798–H803
Hasegawa S, Nakano M, Taniguchi Y, Imai S, Murata K, Suzuki T (1995) Effects of Na+/H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc Drugs Ther 9:823–826
Hileeto D, Cukiernik M, Mukherjee S, Evans T, Barbin Y, Downey D, Karmazyn M, Chakrabarti S (2002) Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev 18:386–394
Hoogerwerf WA, Tsao SC, Devuyst O, Levine SA, Yun CH, et al. (1996) NHE2 and NHE3 are human and rabbit intestinal brush-border proteins. Am J Physiol 270:G29–G41
Jandeleit-Dahm K, Hannan KM, Farrelly CA, Allen TJ, Ruble JR, Gilbert RE, Cooper ME, Little PJ (2000) Diabetes-induced vascular hypertrophy is accompanied by activation of Na+/H+ exchange and prevented by Na+/H+ exchange inhibition. Circ Res 87:1133–1140
Karmazyn M (2001) Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res Cardiol 96:325–328
Karmazyn M (2002) Antiarrhythmic effects of Na+/H+ exchange inhibition. Drug Dev Res 55:22–28
Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K (1999) The myocardial Na+/H+ exchange: structure, regulation, and its role in heart disease. Circ Res 85:777–786
Kawamoto T, Kimura H, Kusumoto K, Fukumoto S, Shiraishi M, Watanabe T, Sawada H (2001) Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559. Eur J Pharmacol 420:1–8
Klein HH, Pich S, Bohle RM, Lindert-Heimberg S, Nebendahl K (2000) Na+/H+ exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual flow. Circulation 102:1977–1982
Knight DR, Smith AH, Flynn DM, MacAndrew JT, Ellery SS, Kong JX, Marala RB, Wester RT, Guzman-Perez A, Hill RJ, Magee WP, Tracey WR (2001) A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J. Pharmacol Exp Ther 297:254–259
Korichneva I, Puceat M, Millanvoye-Van Brussel E, Geraud G, Vassort G (1995) Aldosterone modulates both the Na+/H+ antiport and Cl/HCO3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol 27:2521–2528
Kovar, A, Peters T, Beier N, Derendorf H (2001) Pharmacokinetic/pharmacodynamic evaluation of the NHE inhibitor eniporide. J Clin Pharmacol 41:139–148
Kusuhara M, Takahashi E, Peterson TE, Abe J, Ishida M, Han J, Ulevitch R, Berk BC (1998) P38 kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells. Effects on Na+/H+ exchange and ERK1/2. Circ Res 83:824–831
Kusumoto K, Haist JV, Karmazyn M (2001) Na+/H+ exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am J Physiol 280:H738–H745
Lin X, Barber DL (1996) A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. J Biol Chem 93:12631–12636
Linz W, Jessen T, Becker RHA, Schölkens BA, Wiemer G (1997) Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 96:3164–3172
Linz W, Albus U, Crause P, Jung W, Weichert A, Schölkens BA, Scholz W (1998) Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens 20:733–749
Loennechen JP, Wisloff U, Falck G, Ellingsen O (2002) Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation 105:1380–1386
López-de León A, Rojkind M (1985) A simple method for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737–743
Lorrain J, Briand V, Favennec E, Duval N, Grosset A, Janiak P, Hoornaert C, Cremer G, Latham C, O'Connor S (2000) Pharmacological profile of SL59.1227, a novel inhibitor of the sodium/hydrogen exchanger. Br J Pharmacol 131:1188–1194
Meyer M, Lehnart S, Pieske B, Schlottauer K, Munk S, Holubarsch C, Just H, Hasenfuss G (1996) Influence of endothelin 1 on human atrial myocardium—myocardial function and subcellular pathways. Basic Res Cardiol 91:86–93
Moe OW (1999) Acute regulation of proximal tubule apical membrane Na/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol 10:2412–2425
Moor AN, Fliegel L (1999) Protein kinase mediated regulation of the Na+/H+ exchanger in the rat myocardium by MAP-kinase-dependent pathways. J Biol Chem 274:22985–229992
Moor AN, Murtazina R, Fliegel L (2000) Calcium and osmotic regulation of the Na+/H+ exchanger in neonatal ventricular myocytes. J Mol Cell Cardiol 32:925–936
Moor AN, Gan XT, Karmazyn M, Fliegel L (2001) Activation of Na+/H+ exchanger-directed protein kinases in the ischemic and ischemic-reperfused rat myocardium. J Biol Chem 276:16113–16122
Numata M, Orlowski J (2001) Molecular cloning and characterization of a novel Na+/H+ exchanger localized to the trans-Golgi network. J Biol Chem 276:17387–17394
Numata M, Petrecca K, Lake N, Orlowski J (1998) Identification of a mitochondrial Na+/H+ exchanger. J Biol Chem 273:6951–6959
Orlowski J, Grinstein S (1997) Na+/H+ exchangers of mammalian cells. J Biol Chem 272:22373–22376
Otani H, Uchiyama T, Yamamura T, Nakao Y, Hattori R, Ninomiya H, Kawaguchi H, Osako M, Imamura H (2000) Effects of the Na+/H+ exchange inhibitor cariporide (HOE 642) on cardiac function and cardiomyocyte cell death in rat ischaemic-reperfused heart. Clin Exp Pharmacol Physiol 27:387–393
Palmerini CA, Fini C, Floridi A, Morelli H, Vedovelli A (1985) High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine. J Chromatogr 339:285–292
Putney LK, Denker SP, Barber DL (2002) The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 42:527–552
Raley-Susman KM, Cragoe E-J Jr, Sapolsky RM, Kopito RR (1991) Regulation of intracellular ph in cultured hippocampal neurons by an amiloride-insensitive Na+/H+ exchanger. J Biol Chem 266:2739–2745
Ritter M, Fuerst J, Woll E, Chwatal S, Schwentner M, Lang F, Deetjen P, Paulmichl M (2001) Na+/H+ exchangers: linking osmotic dysequilibrium to modified cell function. Cell Physiol Biochem 11:1–18
Sandmann S, Yu M, Kaschina E, Blume A, Bouzinova E, Aalkjaer C, Unger T (2001) Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+/H+ exchanger and Na+/HCO3 − symporter in the rat heart after myocardial infarction. J Am Coll Cardiol 37:2154–2165
Sandmann S, Kaschina E, Blume A, Kruse ML, Unger T (2003) Bradykinin B1 and B2 receptors differentially regulate cardiac Na+/H+ exchanger and Na+/HCO3 − symporter. Eur J Pharmacol 458:3–16
Schäfer M, Schäfer C, Piper H, Schlüter K-D (2002) Hypertrophic responsiveness of cardiomyocytes to α- or β-adrenoceptor stimulation requires sodium-proton-exchanger-1 (NHE-1) activation but not cellular alkalization. Eur J Heart Fail 4:249–254
Schlüter K-D, Schäfer M, Balser C, Taimor G, Piper HM (1998) Influence of pHi and creatine phosphate on α-adrenoceptor-mediated cardiac hypertrophy. J Mol Cell Cardiol 30:763–771
Scholz W, Albus U, Counillon L, Gögelein H, Lang HJ, Linz W, Weichert A, Schölkens BA (1995) Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion. Cardiovasc Res 29:260–268
Scholz W, Jessel A, Albus U (1999) Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial. J Thromb Thrombolysis 8:61–70
Shinagawa K, Mitamura H, Ogawa S, Nattel S (2002) Effects of inhibiting Na+/H+ exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Can Cardiovasc Res 54:438–446
Spitznagel H, Chung O, Xia QG, Rossius B, Illner S, Jähnchen G, Sandmann S, Reinecke A, Daemen MJAP, Unger T (2000) Cardioprotective effects of the Na+/H+ exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc Res 46:102–110
Takahashi E, Abe J, Berk BC (1997) Angiotensin II stimulates p90rsk in vascular smooth muscle cells: a potential of Na+/H+ exchanger kinase. Hypertension 29:1265–1272
Takahashi E, Abe J, Gallis B, Aebersold R, Spring DJ, et al. (1999) P90RSK is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory phosphorylation of serine 703 of Na+/H+ exchanger isoform-1. J Biol Chem 274:206–214
Takewaki S, Kuro-o M, Hiroi Y, Yamazaki T, Noguchi T, Miyagishi A, Nakahara K, Aikawa M, Manabe I, Yazaki Y, et al. (1995) Activation of Na+/H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cardiol 27:729–742
Taniguchi Y, Nakano M, Hasegawa S, Kanda T, Imai S, Suzuki T, Kobayashi I, Nagai R (1996) Beneficial effect of amiloride, a Na+/H+ exchange blocker, in a murine model of dilated cardiomyopathy. Res Commun Chem Pathol Pharmacol 92:201–210
Theroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson J-T, Jessel A (2000) Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102:3032–3038
Thompson K, Wisenberg G, Sykes RVT, Thompson RT (2003) MRI/MRS evaluation of cariporide in a canine long-term model of reperfused ischemic insults. J. Magn Reson Imaging. 17:136–141
Touret N, Tanneur V, Godart H, Seidler R, Taki N, Bürger E, Dämmgen J, Counillon L (2003) Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur J Pharmacol. 459:151–158
Tracy WR, Allen MC, Frazier DE, Fossa AA, Johnson CG, Marala RB, Knight DR, Guzman-Perez A (2003) Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). Cardiovasc Drug Rev 21:17–32
Tse CM, Levine SA, Yun CH, Montrose MH, Little PJ, et al. (1993) Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2). J Biol Chem 268:11917–11924
Wakabayashi S, Ikeda T, Iwamoto T, Poussegur J, Shigekawa M (1997) Calmodulin-binding autoinhibitory domain controls "pH-sensing" in the Na+/H+ exchanger NHE-1 through sequence specific interaction. Biochemistry 36:12854–12861
Wakabayashi S, Pang T, Su X, Shigekawa M (2000) A novel topology model of the human Na+/H+ exchanger isoform 1. J Biol Chem 275:7942–7949
Wang H, Silva NLCL, Lucchesi PA, Haworth R, Wang K, Michalak M, Pelech S, Fliegel L (1997) Phosphorylation and regulation of the Na+/H+ exchanger through mitogen-activated protein kinase. Biochemistry 36:9151–9158
Wang H, Sakurai K, Endoh M (2000) Pharmacological analysis by HOE642 and KB-R9032 of the role of Na+/H+ exchange in the endothelin-1-induced Ca2+ signalling in rabbit ventricular myocytes. Br J Pharmacol 131:638–644
Wirth KJ, Maier T, Busch AE (2001) NHE-1 inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol 96:192–197
Yamamoto S, Matsui K, Itoh N, Ohashi N (2001) The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts. Int J Tissue React 23:1–7
Yamazaki T, Komuro I, Kudoh S, et al. (1998) Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res 82:430–437
Yasutake M, Haworth RS, King A, Avkiran M (1996) Thrombin activates the sarcolemmal Na+/H+ exchanger. Circ Res 79:705–715
Yokoyama H, Gunasegaram S, Harding SE, Avkiram M (2000) Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium. J Am Col Cardiol 36:534–540
Yoshida, H, Karmazyn M (2000) Na+/H+ exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am J Physiol 278:H300–H304
Zeymer U, Suryapranata H, Monassier JP, et al. (2001) The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: results of the Evaluation of the Safety and Cardioprotective Effects of Eniporide in Acute Myocardial Infarction (ESCAMI) trial. J Am Coll Cardiol 38:1644–1650
Zolk O, Kouchi I, Schnabel P, Böhm M (2000) Heterotrimeric G proteins in heart disease. Can J Physiol Pharmacol 78:187–198
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Linz, W.J., Busch, A.E. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling. Naunyn-Schmiedeberg's Arch Pharmacol 368, 239–246 (2003). https://doi.org/10.1007/s00210-003-0808-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0808-2